Lieve Naesens
- Virology top 0.5%
- HIV Research and Treatment 34
- Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment 83
- Epidemiology top 0.2%
- Influenza Virus Research Studies 59
- Cytomegalovirus and herpesvirus research 47
- Herpesvirus Infections and Treatments 32
- Organic Chemistry top 0.5%
- Pharmaceutical Science top 1%
-
- Biochemical and Molecular Research 51
- RNA and protein synthesis mechanisms 23
-
- Viral-associated cancers and disorders 24
Lieve Naesens
283 papers receiving 9.3k citations
Peers
Comparison fields: 5 of 131
- Virology 1.3k
- Infectious Diseases 3.5k
- Epidemiology 4.4k
- Organic Chemistry 2.2k
- Pharmaceutical Science 379
Countries citing papers authored by Lieve Naesens
This map shows the geographic impact of Lieve Naesens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieve Naesens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieve Naesens more than expected).
Fields of papers citing papers by Lieve Naesens
This network shows the impact of papers produced by Lieve Naesens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieve Naesens. The network helps show where Lieve Naesens may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lieve Naesens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 3 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 6 | |
| 10 | 2017 | 19 | |
| 11 | 2017 | 4 | |
| 12 | Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease | 2013 | 1 |
| 13 | 2008 | 32 | |
| 14 | 2007 | 62 | |
| 15 | 2005 | 166 | |
| 16 | Activity of different classes of nucleoside and nucleotide analogues against adenovirus in cell culture | 2004 | 1 |
| 17 | Susceptibilities of several drug-resistant varicella-zoster virus (VZV) strains to bicyclic pyrimidine nucleoside analogues (BCNAs) | 2002 | 3 |
| 18 | 1998 | 4 | |
| 19 | Therapeutic potential of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) as an antiviral drug | 1994 | 4 |
| 20 | 1992 | 36 |
About Lieve Naesens
Lieve Naesens is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 284 papers that have together received 9.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (83 papers), Influenza Virus Research Studies (59 papers), Biochemical and Molecular Research (51 papers), Cytomegalovirus and herpesvirus research (47 papers), HIV Research and Treatment (34 papers), Herpesvirus Infections and Treatments (32 papers), Viral-associated cancers and disorders (24 papers) and RNA and protein synthesis mechanisms (23 papers). The work is most often cited by research in Virology (1.3k citations), Infectious Diseases (3.5k citations) and Epidemiology (4.4k citations). Lieve Naesens has collaborated with scholars based in Belgium, Czechia and Italy. Frequent co-authors include Erik De Clercq, Jan Balzarini, Robert Snoeck, Antonı́n Holý, Leen De Bolle, Evelien Vanderlinden, Annelies Stevaert, Johan Neyts, Graciela Andreï and Liesbeth Lenaerts. Their work appears in journals such as Antiviral Research, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, European Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.